Skip to main content
. Author manuscript; available in PMC: 2022 Aug 29.
Published in final edited form as: Cell Tissue Res. 2020 Aug 26;382(1):83–100. doi: 10.1007/s00441-020-03263-0

TABLE 1.

Human conditions with reported changes in MANF and CDNF expression

Disease Change Reference
Atrial Fibrillation Decreased MANF mRNA and protein in serum Wang et al 2019
Diabetes Type 1 Increased MANF protein in plasma Galli et al 2016
Diabetes Type 2 Increased MANF protein in plasma Wu et al 2017, Fu et al 2020
Fasting Increased MANF protein in plasma Galli et al 2019a
Hepatocellular carcinoma Increased MANF mRNA and protein in tissue He et al 2020a
Hyperlipidemia Increased MANF protein in serum Fu et al 2020
Nonalcoholic Steatohepatitis Decreased MANF protein in serum Sousa-Victor et al 2019
Parkinson’s disease Increased MANF protein in plasma Galli et al 2019b
Parkinson’s disease Increased CDNF protein in hippocampus Virachit et al 2019
Physiological ageing Decreased MANF protein in plasma Sousa-Victor et al 2019
Polycystic ovary syndrome Decreased MANF protein in plasma Wei et al 2020
Proliferative diabetic retinopathy Increased MANF protein in vitreous Gao et al 2017
Retinal detachment Increased MANF protein in vitreous Gao et al 2017
Rheumatoid arthritis Increased MANF mRNA in white blood cells Chen et al 2015
Stroke Decreased CDNF mRNA levels in blood platelets Joshi et al 2020
Systemic lupus erythematosus Increased MANF mRNA in white blood cells Chen et al 2015